PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of selfLink to Publisher's site
 
Self Nonself. 2010 Jan-Mar; 1(1): 55–61.
PMCID: PMC3091603
On the issue of peptide recognition in T cell development
Travis J Crites and Rajat Varmacorresponding author
Laboratory of Cellular and Molecular Immunology; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda, MD USA
corresponding authorCorresponding author.
Correspondence to: Rajat Varma; Email: varmarajat/at/mail.nih.gov
Received October 29, 2009; Revised December 16, 2009; Accepted December 17, 2009.
CD4–CD8 double positive (DP) thymocytes undergo a differentiation process in the thymus where they are selected based on their ability to recognize peptide antigens presented on self major histocompatibility complex (MHC) molecules. The first stage of this process is positive selection, a quality-control mechanism which ensures that the T cell receptors (TCR) presented on developing thymocytes can transmit signals via peptides presented on either MHC class I (MHC1) or MHC class II (MHC2) molecules. Work over the past decade has revealed that the peptides that drive positive selection of both CD4 and CD8 lineage cells deliver only weak TCR signals. In line with these observations, specialized protein degradation machineries have been discovered in the thymic cortex that presumably generate specialized low-affinity peptide repertoires for presentation on MHC1 and MHC2 molecules. TCR signals transduced through these weak-affinity ligands in the early stages of positive selection alter the kinetics of expression of CD4 and CD8 molecules and play a crucial role in commitment of thymocytes to either the CD4 or CD8 lineages. In this work, we review the experiments that explore the peptide repertoires that are presented to developing thymocytes during positive selection, the observed signaling patterns that lead to CD4 versus CD8 lineage commitment, and speculate about how specialized organization of the signaling machinery in DP thymocytes may allow for efficient transduction of weak signals during the course of positive selection.
Key words: selection, TCR, CD4, CD8, signaling, peptides, microcluster
Before entering the repertoire of mature CD4 or CD8 singlepositive (SP) T cells, immature DP thymocytes undergo a series of selective tests.1 The collective result of these processes is the truncation of the vast TCR repertoire encoded by germline gene segments into a small subset of productive TCRs.2 The selected few can recognize foreign peptides bound by MHC allelic products—but are largely tolerant toward self peptides presented within the context of the same MHC molecules. Currently, it is commonly accepted that the process of generating such a mature T cell repertoire occurs in two steps. In the first step, TCRs receive signals via low affinity recognition of self peptide loaded MHC molecules presented by epithelial cells in the thymic cortex (cTECs).3,4 Thymocytes that signal during this stage will mature into SP thymocytes bearing either a CD4 or CD8 coreceptor. For the purposes of this review, we define positive selection as the collective process by which preselection DP thymocytes are signaled and subsequently commit to either the CD4 or CD8 lineage. T cells that do not recognize any self peptide-MHC complexes die by neglect. In the second step, SP thymocytes expressing TCRs which show strong interactions toward host-derived peptide-MHC complexes presented mostly by antigen presenting cells (APCs) in the thymic medulla (mTECs) are negatively selected.5 Negative selection is thought to be mediated at least in part by promiscuous gene expression of peripheral tissue antigens via the transcription factor AIRE in the medullary epithelium.6 AIRE is also believed to be a proapoptotic factor for mTECs, such that these antigens are released into the medulla for cross presentation by resident dendritic cells.7 Recent two-photon imaging studies lend further credence to the view that positive and negative selection are distinct processes which occur in specialized regions of the thymus. While DP thymocytes were confined and migrated randomly within the cortical regions of the thymus, SP thymocytes moved directionally toward the medulla where they again accumulated.8 Historically, the requirement for recognition of nominally similar repertoires of peptide-MHC complexes for both survival of a select population and the death of others has been referred to as the selection paradox.
Our understanding of how TCR recognizes peptide-MHC complexes has been greatly advanced over the past two decades by studying the interaction between TCR transgenic T cells and their well-defined peptide-MHC complex ligands. We have gleaned much about the kinetics of these interactions from biophysical studies, and attempts have been made to correlate these kinetic parameters with signaling outcomes.911 As we will present, much work has been done to determine the types of peptides that are capable of promoting positive selection of polyclonal T cell populations, but information about the identity of the actual peptides involved in in vivo selection is still limited. Identification of these peptides remains an issue of great interest not only due to their role in facilitating the signaling required for selection processes but also because low-affinity interactions resembling those encountered during positive selection seem to be important for homeostasis of mature T cells in the periphery.12,13 We propose that sustained TCR signaling required for positive selection and lineage commitment is generated by serial, sometimes promiscuous, engagements with low-affinity self peptide MHC-complexes in the thymic cortex. Here we review the experiments done to determine the types of peptide repertoires that promote positive selection, how they are produced in vivo, and provide speculation about the organization of the signaling machinery that may explain the aforementioned patterns of signaling.70
The kinetic signaling model proposes that all DP thymocytes are preprogrammed to initially downregulate CD8 expression upon transduction of signals through their TCRs. The factor that determines commitment to the CD4 or CD8 lineage after repression of CD8 expression is the ability or inability to sustain signaling through the TCR. Those which continue to signal past CD8 repression in response to MHC2 ligands and continue to maintain high CD4 expression will commit to the CD4 lineage; others will commit to the CD8 lineage. Bosselut and colleagues demonstrated that when both endogenous CD8 and CD8 under the control of the hCD2 promoter are coexpressed in the same thymocytes, only the CD8 controlled by the endogenous promoter is downregulated upon TCR signaling.14 From these experiments, they concluded that the CD8 gene is transcriptionally repressed by TCR signaling in the DP stage. If the TCR present on the CD4 high, CD8 low thymocytes recognize MHC2 bound peptides, continued signaling through the TCR promotes the continued repression of CD8 expression and upregulation of CD4 transcription. Alternatively, if no signal is relayed through MHC2-bound peptides, coreceptor inversion ensues, and signals transduced through MHC1-bound peptides will effect commitment to the CD8 lineage. When Zap70 expression is confined to the DP stage, TCR signaling past this developmental stage is disrupted, and TCRs that are normally MHC2 restricted mature into the CD8 lineage.15 In line with these data, Sarafova et al. demonstrated that, when transgenic CD4 molecules are downregulated under the control of a heterologous promoter during DP thymocyte signaling, MHC2 restricted thymocytes are again directed into the CD8 lineage.16 Thus, continuous TCR signaling is necessary for commitment of DP thymocytes into the CD4 lineage. Evidence does exist, however, that transient downregulation of CD8 expression is not absolutely essential for direction of thymocytes into the CD8 lineage. In the H-Y antigen specific system, Robey et al. demonstrated that thymocytes that constitutively express transgenic CD8αβ along with the H-Y TCR were positively selected at a 5- to 6-fold higher frequency than thymocytes expressing only TCR and endogenous CD8.17 Could a peptide repertoire that encourages continuous signaling through MHC2 restricted TCRs but frustrates signaling through the MHC1-restricted counterparts explain the observed signaling pattern? The experimental evidence for the types of peptides presented on MHC1 or MHC2 molecules in the thymic cortex appear consistent with this conjecture, as we describe below.
Initial experimental systems used to define the nature of the positively selecting peptide repertoire in the thymus aimed to trim the repertoire to either a single peptide or sparse mixtures of peptides presented either on MHC1 or MHC2. Such systems allowed researchers to question whether special peptides were being generated solely for the purpose of carrying out positive selection. To study MHC1 restricted positive selection, β-2 microglobulin (β-2m)18 and TAP119,20 knockout (KO) mice which effectively abrogated CD8 lineage T cell development were used. In these mice, the deletion of TAP1 or β-2m results in a drastic reduction in surface expression of MHC1. An increase in the level of MHC complexes ensues when exogenous peptides are added to TAP1-deficient cultures. In the case of β-2m deficient mice, the combined addition of recombinant β-2m and exogenous peptide stabilizes surface expression of MHC1 molecules, hence resulting in an increase in MHC1 surface levels.18 Experiments were conducted in which thymocytes expressing particular MHC1 restricted transgenic TCRs were added into TAP1 and β-2m knockout fetal thymic organ culture (FTOC). Agonists or altered peptide ligands (APLs) for the TCR were then systematically added back to cultures in an effort to determine the identity of peptides capable of selecting them. For the lymphocytic choriomeningitis virus (LCMV) peptide specific TCR clone, P14, low and high concentrations of the LCMV peptide agonist added to the TAP1 KO FTOC caused positive and negative selection, respectively.21 When the peptide was added back to the TAP1- sufficient FTOC, however, negative selection was induced even at low peptide concentrations. For the same TCR in the β-2m KO system, a qualitatively similar relationship was found where higher concentrations of peptide induced negative selection, while lower amounts induced positive selection.22 A different strain of mice was bred which displayed Ld at either 35 or 2% of total MHC1 occupancy. These thymi were tested for their ability to positively select the 2C TCR which is normally negatively selected on Ld.23 Although negative selection proceeded normally in the 35% Ld thymus, the 2C TCR was positively selected in the 2% Ld thymus. Further work in the β-2m KO system showed that an antagonist APL of a TCR specific for OVA peptide presented on Kb supported positive selection of T cells that expressed normal amounts of CD8 and TCR.24 But when the antagonist was presented in the β-2m (+/-) system, it resulted in negative selection. Work in the F5 TCR model, specific for a peptide derived from the nucleoprotein of Influenza A, demonstrated that an antagonistic APL positively selected two times more thymocytes than the agonist peptide added to TAP1 deficient FTOC at identical concentrations.25 More recently, mice were generated in which MHC1 molecules containing a single peptide were presented to a polyclonal population of developing thymocytes.26 In this system, only 10% of the normal number of CD8 lineage cells developed. Although individual TCRs must have been selected by promiscuous recognition of the same peptide, mature T cells taken from these animals after immunization with particular peptides showed strict peptide specificity, as judged by in vitro lysis of target cells loaded with the peptide used for immunization. Taken together, the body of work indicates that positive selection shows exquisite sensitivity for the strength of signal.
The next step in identification of positively selecting peptides led researchers to begin the difficult task of purifying peptides eluted from MHC1 molecules from wild-type thymi. For the OT-1 transgenic system, Hogquist et al. found seven naturally-occurring peptides which were capable of interacting with the TCR.27 Capability of interaction with the TCR was gauged by culturing thymocytes with APCs presenting the various eluted peptides to mimic negative selection, which was manifested by “dulling” of coreceptor expression. Using a mass-spectrometry analysis, the identity of one of the peptides was determined, and they showed by FTOC add back experiments that it was capable of supporting positive selection. The sequence of the peptide, however, was only related to the agonist peptide at a few positions near the C terminus. Further work from the group using more sensitive detection techniques combined with bioinformatics tools rediscovered this peptide along with another derived from β-catenin.28 The latter peptide acts as an antagonist for mature OT-I T cells, shares significant homology with the agonist ligand and is capable of supporting positive selection.
Consistent with the observation that limited TCR signaling during positive selection directs cells into the CD8 lineage and the demonstrated role for TCR antagonists, recent work has now shown that the antigen-processing machinery in the thymic cortex is poised to generate a repertoire of peptide-MHC complexes that is likely inhibitory toward MHC1 restricted TCR signaling.2931 A special proteosome, aptly termed the thymoproteosome, has recently been described. It is expressed in 70–80% of cTECs and has not been detected in other tissues. Due to the incorporation of the special subunit, β5t, into the 20s proteolytic site of the traditional proteosome, the thymoproteosome does not cleave polypeptides at hydrophobic amino acid residues. A review of biophysical data of the nearly 1,500 peptides presented by human MHC1 alleles showed that 80% of peptides loaded with high affinity possess hydrophobic amino acids at the C terminus.30 The N terminal anchor shows less stringent specificity. Neither the thymic architecture nor the level of MHC1 expression are altered in mice deficient in the β5t subunit, but the knockout does result in a reduction in the number of CD8 T cells expressing high levels of TCR.31 CD4 lineage T cell development in these animals remains unaffected. Others have suggested that MHC1 molecules loaded with low-binding affinity peptides, like those generated by cTECs, imply that two types of MHC ligands which have not been traditionally regarded as ligands for positive selection are likely to be presented on cTECs.32 These namely include MHC-peptide complexes in which only one side of the peptide is anchored or empty MHC molecules from which peptides have completely disassociated. Antibodies that recognize MHC molecules in a peptide-dependent and independent manner have provided supporting evidence for the presence of such complexes on cortical cells but not within the medulla.33 The presentation of these types of MHC ligands, then, could be a mechanism that precludes high-affinity interactions between TCR and peptide-MHC1 complexes during positive selection. Since knockout of the β5t subunit does not significantly alter MHC1 expression, its role could be envisioned as diluting the pool of available positively selecting interactions such that signaling through MHC1-restricted TCRs happens only very infrequently, allowing CD8 T cell lineage commitment to occur.
For the study of MHC2 restricted positive selection, model systems were generated in which single peptides were presented to developing polyclonal thymocytes. MHC2 molecules are synthesized and transported to peptide loading compartments associated with the Invariant chain (Ii).34 The segment of the Ii loaded in the groove of MHC2 is known as the CLIP peptide. At this stage, the Ii is trimmed, resulting in CLIP peptide loaded MHC2 molecules. H-2M then chaperones the loading of other peptides to replace the CLIP peptide. In the H-2M knockout mouse, surface MHC2 molecules are almost exclusively loaded with CLIP.35,36 This system supported the development of a repertoire 50% of the normal size.36,37 A similar line of mice was developed in which the Invariant chain was knocked out, and a transgene encoding a mutated Invariant chain was inserted. The Eα peptide replaced the CLIP region of the Invariant chain,38 and 95% of MHC2 molecules presented the Eα peptide. Normal numbers of CD4 lineage T cells managed to develop. Observations from these systems initially supported the notion that MHC2-dependent positive selection is almost wholly degenerate with respect to peptide recognition. Further experiments, however, in both the H-2M knockout and Ii:pEα mice disputed that conclusion. When MHC2 molecules containing non-CLIP peptides were excluded via antibody blockade in H-2M knockout FTOC, CD4 lineage T cell selection was significantly diminished.39 Likewise, in the Ii:pEα mice, when H-2M was knocked out, 70% of the T cells which had previously developed were lost.38 Complementary to this observation, it was shown that 70–80% of TCRs selected on a predominant CLIP epitope were not tolerant and should have been negatively selected as judged by reactivity toward wild-type splenic APCs.40 In combination, it was possible to conclude that the small fraction of self peptides being presented at very low levels in both of the mice were responsible for effectuating the majority of the positive selection which was occurring.41
Experiments were also conducted to determine the ability of specific APLs to induce positive selection of CD4 lineage transgenic T cells. For a pigeon cytochrome C (PCC)[43–58] peptidespecific TCR, injections of agonist peptide alone or a mixture of antagonist and agonist peptides were given to Ii, H-2M double KO mice.42 When injected alone, agonist peptide presumably repopulated MHC molecules in the thymus and supported positive selection of the transgenic T cells that continued for up to 2 weeks. Coinjection of antagonist peptide disrupted the positive selection. With the 2B4 TCR specific for pigeon cytochrome C (PCC) peptide, Spain et al. demonstrated via an FTOC approach that antagonist APLs block positive selection, and agonist peptides induce deletion.43 The differences in outcome achieved with injected agonist peptides may be due to less efficient restoration of peptide presentation within the thymus. More than a decade passed before experiments were conducted to determine the identity of natural peptides that positively select MHC2 restricted TCRs, which were sought out largely as tools for studying signaling in mature, peripheral T cells in response to peptides that promoted their positive selection. For both the AND and 5C.C7 TCRs, peptides from libraries were screened for their ability to sustain positive selection.44,45 For the 5C.C7 TCR, using an FTOC approach, a handful of peptides were identified, and the peptide that supported the greatest development of CD4 cells was structurally related to its natural agonist, PCC.44 A similar library-screening approach was used to identify positively selecting ligands for the AND TCR.45 Of 95 peptides in the library, only one was shown to support positive selection of thymocytes bearing the AND receptor—gp250, derived from a protein with no relationship to the natural source of the agonist ligand and nonhomologous to the agonist peptide. Both identified ligands for these MHC2-restricted TCRs were able to augment the activation and survival of peripheral CD4 lineage T cells,44 in seeming contrast to the antagonistic ligands involved in the selection of MHC1 restricted T cells.
In the processing of peptides presented on MHC2 molecules, a proteolytic pathway that operates exclusively in the thymic cortex has been identified.46,47 Cathepsin L is a lysosomal endoproteinase responsible for degradation of Ii solely in the thymic cortex. Staining with an antibody specific for I-Ab complexed to CLIP showed increased staining of the cortex of cathepsin L KO mice versus wild-type animals, while staining of the medulla was similar in both cases. Flow cytometric analysis performed on peripheral lymphoid cells did not show skewing toward exclusive presentation of the CLIP peptide, furthering the case for altered MHC2 antigen presentation in the thymic cortex.46 In the KO mouse, a 60–80% reduction in the generation of CD4+ T cells is observed along with a relative increase in the number of CD8 lineage cells. The method by which cathepsin L ultimately mediates presentation of a distinct class of positively selecting peptides still remains unclear.
When T cells interact with APCs, a patterning of interactions takes place in the interface connecting the two cells. This patterning has been described as an immunological synapse, which is characterized by a bull's eye pattern consisting of TCR-peptide-MHC interactions in a central cluster surrounded by a ring of adhesion molecules.48,49 More recently, a smaller scale clustering of TCRs in response to peptide-MHC has been demonstrated, and these structures have been called TCR microclusters.5052 These microclusters are dynamically formed at the periphery of the contact area where they engage antigen and initiate signaling.53,54 Signaling molecules and kinases, such as Lck, Zap–70, LAT, SLP-76,50,52,54 and Grb2,55 are localized to TCR microclusters, which translocate from the periphery of the synapse to the center in an actin dependent manner where signaling is terminated,51 although the precise function of the cSMAC remains unresolved.56 TCR microclusters form continuously, thus providing a mechanism for sustained signaling. Interestingly, CD28 interactions with CD80 or CTLA-4 have also been shown to localize to the microclusters.57,58 Neither the molecular mechanisms nor the physical properties that localize these co-stimulatory interactions to microclusters are known, but they highlight the importance of microclusters as a specialized site for signaling. Quantitative analysis of TCR numbers demonstrated that the ratio of TCR to peptide-MHC complexes within a microcluster is large. Hence, high TCR density seems to be required for TCR microcluster formation, although one report demonstrated that mature CD8 lineage cells displaying 1,000 or less TCRs (1/20th of the normal level) were capable of both proliferation and cytokine production in response to in vivo immunization with agonist peptide.59 The localization of CD4 or CD8 co-receptors with respect to TCR microclusters is not known, although models of TCR triggering such as the pseudo-dimer model60 would predict the localization of CD4 to TCR microclusters. As a result, the method by which CD4 or CD8 might contribute to microcluster formation is not known. It is however known that active signaling via Src family kinases is not required for microcluster formation.50
While the recognition of self-peptide MHC complexes in the thymus is certainly similar to recognition of antigen in the periphery, the responses of DP thymocytes to the peptide-MHC complexes presented in the thymus are distinct. DP thymocytes probably have a very different distribution of signaling molecules (kinases, phosphatases and adapters) compared to peripheral T cells. This is partially reflected by the differential expression of micro-RNA, mir-181a, that is expressed only in thymocytes and downregulates phosphatase expression in DP cells.44,61 When thymocytes interact with APCs bearing positively selecting ligands, there is no formation of an immunological synapse.62 And in direct contrast, transgenic DP thymocytes interacting with negatively selecting ligands form a structure in which multiple TCR-rich foci with extensive tyrosine phosphorylation are present.63 Two photon imaging of thymocytes interacting with stromal cells in thymic organ culture showed thymocytes displaying both long-lived contacts and transient interactions.64 Further studies in which thymocytes were visualized in thymic tissue sections revealed that thymocyte stopping correlated with sustained oscillations in the concentration of intracellular calcium,65 which is reminiscent of the stopping behavior of mature T cells in response to agonist peptides. Additionally, Davey et al. demonstrated that while preselection DP thymocytes, SP thymocytes and mature T cells in the OT-I transgenic system upregulate CD69 equivalently when stimulated with strong agonist ligands, only preselection DP thymocytes show upregulation in response to agonists of weaker affinity.66 Similarly, in the 5C.C7 system, 90% of DP thymocytes upregulated CD69 in response to a low affinity APL at a peptide dose of 1 µM, while a maximum of 40% of mature T cells showed upregulation at a 100-fold higher peptide dose.67 And as a further indication of the heightened sensitivity of thymocytes to TCR signals, it has been recently shown that as few as two agonist peptide-MHC complexes could induce apoptosis of DP thymocytes.62 Thus, by virtue of their distinct phenotype, thymocytes are poised to react differently to the same types of signals received by mature T cells. While mature T cells are singly positive for either CD4 or CD8 and specific toward peptide epitopes presented either by MHC1 or MHC2, preselection thymocytes are doubly positive for both coreceptors and express them at elevated levels. One consequence of high levels of coreceptor expression is that Lck in DP thymocytes can be sequestered to the tails of the CD4 and CD8 coreceptors,68 perhaps allowing for rapid and highly efficient phosphorylation of ITAMS in response to TCR triggering.
Based on these observations, we propose that the specificity of peptide recognition by thymocytes during T cell development exists as a continuum (Fig. 1). During the initial phase of positive selection (Fig. 1, P1) when TCR levels are low, the dual presence of both CD4 and CD8 coreceptors serves to stabilize all available interactions between TCR and peptide-MHC complexes. Due to the possible presence of a large proportion of suboptimal ligands, these interactions are likely to dictate microcluster formation in an entirely peptide promiscuous manner. This raises the possibility that when DP thymocytes can recognize self-peptide-MHC complexes and do not die by neglect, they form signaling microclusters containing TCR, CD4 and CD8 that may recognize many self-peptide-MHC complexes. This promiscuous signal transduction would be amplified by the reduction in phosphatase activity in DP thymocytes described previously. As signals are transduced through TCRs on DP cells, upregulation of CD4 transcription ensues, TCR levels begin to rise, and surface expression of CD8 wanes. In this second phase (Fig. 1, P2), the patterns of TCR signaling will dictate lineage commitment. Signaling microclusters may now contain only CD4 and TCR, requiring peptide-MHC recognition to become more specific. If the TCR recognizes peptides presented by resident MHC2 complexes with high enough affinity to sustain TCR signals, the cell will commit to the CD4 lineage. If not, CD4 transcription will be silenced, and coreceptor inversion will occur. In this third phase, (Fig. 1, P3), TCR microclusters will now predominantly contain CD8 and TCR, and commitment to the CD8 lineage will depend on the ability of the TCR to transmit signals via recognition of peptides presented on MHC1 molecules. An analysis of peptides generated in the cortex suggests that the thymoproteosome exists to limit the presentation of stimulatory peptides by MHC1 molecules; however, this may be compensated for by the relatively high affinity of CD8 for MHC1, which would permit signaling via low abundance MHC1-peptide complexes in the thymus. In fact, the lack of sialic acid capping of CD8 in thymocytes has been shown to increase the avidity of the CD8-MHC1 interaction.69 Finally, these lineage-committed SP cells will proceed forward to be tested for reactivity towards specific self peptides during the process of negative selection. Thus, our model for T cell selection contends that thymocytes will recognize peptide-MHC complexes with a spectrum of affinities that is dictated by the dynamics of the organization of TCR microclusters as they proceed through the gauntlet of thymic selection.
Figure 1
Figure 1
Stage dependent TCR microcluster formation during positive selection. TCR-low preselection DP thymocytes enter the first phase (P1) of positive selection during which transduction of weak signals is facilitated by specialized TCR microclusters (lower) (more ...)
1. Nitta T, Murata S, Ueno T, Tanaka K, Takahama Y. Thymic microenvironments for T-cell repertoire formation. Adv Immunol. 2008;99:59–94. [PubMed]
2. Bevan MJ. In thymic selection, peptide diversity gives and takes away. Immunity. 1997;7:175–178. [PubMed]
3. Allen PM. Peptides in positive and negative selection: a delicate balance. Cell. 1994;76:593–596. [PubMed]
4. von Boehmer H. Positive selection of lymphocytes. Cell. 1994;76:219–228. [PubMed]
5. Ashton-Rickardt PG, Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today. 1994;15:362–366. [PubMed]
6. Mathis D, Benoist C. Aire. Annu Rev Immunol. 2009;27:287–312. [PubMed]
7. Gallegos AM, Bevan MJ. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med. 2004;200:1039–1049. [PMC free article] [PubMed]
8. Ehrlich LI, Oh DY, Weissman IL, Lewis RS. Differential contribution of chemotaxis and substrate restriction to segregation of immature and mature thymocytes. Immunity. 2009;6:986–998. [PubMed]
9. Alam SM, Davies GM, Lin CM, Zal T, Nasholds W, Jameson SC, et al. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity. 1999;10:227–237. [PubMed]
10. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, et al. T-cell-receptor affinity and thymocyte positive selection. Nature. 1996;381:616–620. [PubMed]
11. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature. 2006;444:724–729. [PubMed]
12. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity. 1999;11:173–181. [PubMed]
13. Kieper WC, Burghardt JT, Surh CD. A role for TCR affinity in regulating naive T cell homeostasis. J Immunol. 2004;172:40–44. [PubMed]
14. Bosselut R, Guinter TI, Sharrow SO, Singer A. Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes “paradoxically” appear as CD4+ 8lo transitional cells during positive selection of CD8+ T cells. J Exp Med. 2003;197:1709–1719. [PMC free article] [PubMed]
15. Liu X, Bosselut R. Duration of TCR signaling controls CD4CD8 lineage differentiation in vivo. Nat Immunol. 2004;5:280–288. [PubMed]
16. Sarafova SD, Van Laethem F, Adoro S, Guinter T, Sharrow SO, Feigenbaum L, et al. Upregulation of CD4 expression during MHC class II-specific positive selection is essential for error-free lineage choice. Immunity. 2009;31:480–490. [PMC free article] [PubMed]
17. Robey EA, Fowlkes BJ, Gordon JW, Kioussis D, von Boehmer H, Ramsdell F, et al. Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage. Cell. 1991;64:99–107. [PubMed]
18. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-microglobulin deficient mice lack CD4β8+ cytolytic T cells. Nature. 1990;344:742–746. [PubMed]
19. Ashton-Rickardt PG, Van Kaer L, Schumacher TN, Ploegh HL, Tonegawa S. Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus. Cell. 1993;73:1041–1049. [PubMed]
20. Aldrich CJ, Ljunggren HG, Van Kaer L, Ashton-Rickardt PG, Tonegawa S, Forman J. Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice. Proc Natl Acad Sci USA. 1994;91:6525–6528. [PubMed]
21. Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 1994;76:651–663. [PubMed]
22. Sebzda E, Wallace VA, Mayer J, Yeung RS, Mak TW, Ohashi PS. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 1994;263:1615–1618. [PubMed]
23. Cook JR, Wormstall EM, Hornell T, Russell J, Connolly JM, Hansen TH. Quantitation of the cell surface level of Ld resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo. Immunity. 1997;7:233–241. [PubMed]
24. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17–27. [PubMed]
25. Smyth LA, Williams O, Huby RD, Norton T, Acuto O, Ley SC, et al. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. Proc Natl Acad Sci USA. 1998;95:8193–8198. [PubMed]
26. Wang B, Primeau TM, Myers N, Rohrs HW, Gross ML, Lybarger L, et al. A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire. Science. 2009;326:871–874. [PMC free article] [PubMed]
27. Hogquist KA, Tomlinson AJ, Kieper WC, McGargill MA, Hart MC, Naylor S, et al. Identification of a naturally occurring ligand for thymic positive selection. Immunity. 1997;6:389–399. [PubMed]
28. Santori FR, Kieper WC, Brown SM, Lu Y, Neubert TA, Johnson KL, et al. Rare, structurally homologous self-peptides promote thymocyte positive selection. Immunity. 2002;17:131–142. [PubMed]
29. Murata S, Takahama Y, Tanaka K. Thymoproteasome: probable role in generating positively selecting peptides. Curr Opin Immunol. 2008;20:192–196. [PubMed]
30. Takahama Y, Tanaka K, Murata S. Modest cortex and promiscuous medulla for thymic repertoire formation. Trends Immunol. 2008;29:251–255. [PubMed]
31. Murata S, Sasaki K, Kishimoto T, Niwa S, Hayashi H, Takahama Y, et al. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science. 2007;316:1349–1353. [PubMed]
32. Ziegler A, Muller CA, Bockmann RA, Uchanska-Ziegler B. Low-affinity peptides and T-cell selection. Trends Immunol. 2009;30:53–60. [PubMed]
33. Rehm A, Rohr A, Seitz C, Wonigeit K, Ziegler A, Uchanska-Ziegler B. Structurally diverse forms of HLA-B27 molecules are displayed in vivo in a cell type-dependent manner. Hum Immunol. 2000;61:408–418. [PubMed]
34. Benham A, Tulp A, Neefjes J. Synthesis and assembly of MHC-peptide complexes. Immunol Today. 1995;16:359–362. [PubMed]
35. Martin WD, Hicks GG, Mendiratta SK, Leva HI, Ruley HE, Van Kaer L. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation and T cell repertoire selection. Cell. 1996;84:543–550. [PubMed]
36. Miyazaki T, Wolf P, Tourne S, Waltzinger C, Dierich A, Barois N, et al. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell. 1996;84:531–541. [PubMed]
37. Fung-Leung WP, Surh CD, Liljedahl M, Pang J, Leturcq D, Peterson PA, et al. Antigen presentation and T cell development in H2-M-deficient mice. Science. 1996;271:1278–1281. [PubMed]
38. Barton GM, Rudensky AY. Requirement for diverse, low-abundance peptides in positive selection of T cells. Science. 1999;283:67–70. [PubMed]
39. Grubin CE, Kovats S, deRoos P, Rudensky AY. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity. 1997;7:197–208. [PubMed]
40. Surh CD, Lee DS, Fung-Leung WP, Karlsson L, Sprent J. Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. Immunity. 1997;7:209–219. [PubMed]
41. Barton GM, Rudensky AY. Evaluating peptide repertoires within the context of thymocyte development. Semin Immunol. 1999;11:417–422. [PubMed]
42. Kraj P, Pacholczyk R, Ignatowicz H, Kisielow P, Jensen P, Ignatowicz L. Positive selection of CD4(+) T cells is induced in vivo by agonist and inhibited by antagonist peptides. J Exp Med. 2001;194:407–416. [PMC free article] [PubMed]
43. Spain LM, Jorgensen JL, Davis MM, Berg LJ. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J Immunol. 1994;152:1709–1717. [PubMed]
44. Ebert PJ, Jiang S, Xie J, Li QJ, Davis MM. An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol. 2009;10:1162–1169. [PubMed]
45. Lo WL, Felix NJ, Walters JJ, Rohrs H, Gross ML, Allen PM. An endogenous peptide positively selects and augments the activation and survival of peripheral CD4+ T cells. Nat Immunol. 2009;10:1155–61. [PMC free article] [PubMed]
46. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science. 1998;280:450–453. [PubMed]
47. Honey K, Nakagawa T, Peters C, Rudensky A. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J Exp Med. 2002;195:1349–1358. [PMC free article] [PubMed]
48. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 1998;395:82–86. [PubMed]
49. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, et al. The immunological synapse: a molecular machine controlling T cell activation. Science. 1999;285:221–227. [PubMed]
50. Campi G, Varma R, Dustin ML. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med. 2005;202:1031–1036. [PMC free article] [PubMed]
51. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity. 2006;25:117–127. [PMC free article] [PubMed]
52. Yokosuka T, Sakata-Sogawa K, Kobayashi W, Hiroshima M, Hashimoto-Tane A, Tokunaga M, et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol. 2005;6:1253–1262. [PubMed]
53. Bunnell SC, Hong DI, Kardon JR, Yamazaki T, McGlade CJ, Barr VA, et al. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J Cell Biol. 2002;158:1263–1275. [PMC free article] [PubMed]
54. Bunnell SC, Kapoor V, Trible RP, Zhang W, Samelson LE. Dynamic actin polymerization drives T cell receptor-induced spreading: a role for the signal transduction adaptor LAT. Immunity. 2001;14:315–329. [PubMed]
55. Huse M, Klein LO, Girvin AT, Faraj JM, Li QJ, Kuhns MS, et al. Spatial and temporal dynamics of T cell receptor signaling with a photoactivatable agonist. Immunity. 2007;27:76–88. [PubMed]
56. Cemerski S, Das J, Giurisato E, Markiewicz MA, Allen PM, Chakraborty AK, et al. The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality. Immunity. 2008;29:414–422. [PubMed]
57. Yokosuka T, Kobayashi W, Sakata-Sogawa K, Takamatsu M, Hashimoto-Tane A, Dustin ML, et al. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation. Immunity. 2008;29:589–601. [PMC free article] [PubMed]
58. Yokosuka T, Saito T. Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters. Immunol Rev. 2009;229:27–40. [PubMed]
59. Labrecque N, Whitfield LS, Obst R, Waltzinger C, Benoist C, Mathis D. How much TCR does a T cell need? Immunity. 2001;15:71–82. [PubMed]
60. Krogsgaard M, Li QJ, Sumen C, Huppa JB, Huse M, Davis MM. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature. 2005;434:238–243. [PubMed]
61. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147–161. [PubMed]
62. Ebert PJ, Ehrlich LI, Davis MM. Low ligand requirement for deletion and lack of synapses in positive selection enforce the gauntlet of thymic T cell maturation. Immunity. 2008;29:734–745. [PubMed]
63. Hailman E, Burack WR, Shaw AS, Dustin ML, Allen PM. Immature CD4(+)CD8(+) thymocytes form a multifocal immunological synapse with sustained tyrosine phosphorylation. Immunity. 2002;16:839–848. [PubMed]
64. Bousso P, Bhakta NR, Lewis RS, Robey E. Dynamics of thymocyte-stromal cell interactions visualized by two-photon microscopy. Science. 2002;296:1876–1880. [PubMed]
65. Bhakta NR, Oh DY, Lewis RS. Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nat Immunol. 2005;6:143–151. [PubMed]
66. Davey GM, Schober SL, Endrizzi BT, Dutcher AK, Jameson SC, Hogquist KA. Preselection thymocytes are more sensitive to T cell receptor stimulation than mature T cells. J Exp Med. 1998;188:1867–1874. [PMC free article] [PubMed]
67. Lucas B, Stefanova I, Yasutomo K, Dautigny N, Germain RN. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity. 1999;10:367–376. [PubMed]
68. Van Laethem F, Sarafova SD, Park JH, Tai X, Pobezinsky L, Guinter TI, et al. Deletion of CD4 and CD8 coreceptors permits generation of αβT cells that recognize antigens independently of the MHC. Immunity. 2007;27:735–750. [PubMed]
69. Moody AM, North SJ, Reinhold B, Van Dyken SJ, Rogers ME, Panico M, et al. Sialic acid capping of CD8β core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. The J Biol Chem. 2003;278:7240–7246. [PubMed]
70. Singer A. New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4/CD8 lineage decision. Curr Opin Immunol. 2002;14:207–215. [PubMed]
Articles from Self Nonself are provided here courtesy of
Landes Bioscience